323 related articles for article (PubMed ID: 12207349)
1. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
2. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
[TBL] [Abstract][Full Text] [Related]
3. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
Calarota SA; Kjerrström A; Islam KB; Wahren B
Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
[TBL] [Abstract][Full Text] [Related]
4. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
5. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
6. Evasion of cytotoxic T lymphocytes is a functional constraint maintaining HIV-1 Nef expression.
Ali A; Ng HL; Dagarag MD; Yang OO
Eur J Immunol; 2005 Nov; 35(11):3221-8. PubMed ID: 16206233
[TBL] [Abstract][Full Text] [Related]
7. CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV-1-infected target cells.
De Maria A; Colombini S; Schnittman SM; Moretta L
Eur J Immunol; 1994 Mar; 24(3):531-6. PubMed ID: 7907291
[TBL] [Abstract][Full Text] [Related]
8. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
Rivière Y
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
[TBL] [Abstract][Full Text] [Related]
10. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines.
Wilson CC; Olson WC; Tuting T; Rinaldo CR; Lotze MT; Storkus WJ
J Immunol; 1999 Mar; 162(5):3070-8. PubMed ID: 10072560
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
[TBL] [Abstract][Full Text] [Related]
12. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
[TBL] [Abstract][Full Text] [Related]
13. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
14. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
[TBL] [Abstract][Full Text] [Related]
15. Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL.
Motozono C; Yanaka S; Tsumoto K; Takiguchi M; Ueno T
J Immunol; 2009 May; 182(9):5528-36. PubMed ID: 19380801
[TBL] [Abstract][Full Text] [Related]
16. Loss of T-cell cytotoxic responses in the course of HIV-1 infection.
Zerhouni B; Sanhadji K; Touraine JL
Thymus; 1997; 24(4):203-19. PubMed ID: 9493284
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
Casement KS; Nehete PN; Arlinghaus RB; Sastry KJ
Virology; 1995 Aug; 211(1):261-7. PubMed ID: 7645219
[TBL] [Abstract][Full Text] [Related]
18. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
19. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
McKinney DM; Lewinsohn DA; Riddell SR; Greenberg PD; Mosier DE
J Immunol; 1999 Jul; 163(2):861-7. PubMed ID: 10395680
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vpr does not inhibit CTL-mediated apoptosis of HIV-1 infected cells.
Lewinsohn DA; Lines R; Lewinsohn DM; Riddell SR; Greenberg PD; Emerman M; Bartz SR
Virology; 2002 Mar; 294(1):13-21. PubMed ID: 11886261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]